|
Market Closed -
Other stock markets
|
After hours 03:55:17 | |||
| 207.93 USD | -0.62% |
|
207.12 | -0.39% |
| 07-30 | BMO Capital Adjusts Price Target on Biogen to $208 From $196, Maintains Market Perform Rating | MT |
| 07-30 | TD Cowen Adjusts Price Target on Biogen to $225 From $215, Maintains Buy Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BIOGEN INC. | Biopharmaceuticals | -0.62% | +3.64% | +18.15% | +64.19% | -36.36% | 30.72B |  | |  |
- Stock Market
- Stocks
- BIIB Stock
- Charts Biogen Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
